Mural Oncology PLC Sustainability Reports
Mural Oncology PLC develops innovative therapies for cancer treatment as a publicly traded biopharmaceutical company.
Sector: Health Care
Country: Ireland
Exchange: Nasdaq Stock Market
ISIN: IE000LK2BOB4
2 reports from 2023 to 2024
Company Profile
Mural Oncology PLC
Mural Oncology PLC develops innovative therapies for cancer treatment as a publicly traded biopharmaceutical company.
Reports